EUVIMEDEUVIMED entdecken
Crossref

The single cell immunogenomic landscape after neoadjuvant immunotherapy combined chemotherapy in esophageal squamous cell carcinoma

Zheyi Wang, Yue Zhao, Yang Wo, Yizhou Peng, Weilei Hu, Zhigang Wu, Pengcheng Liu, Yan Shang, Chunnan Liu, Xiao Chen, Kan Huang, Yuting Chen und 3 weitere

Cancer Letters · 2024

DOI: 10.1016/j.canlet.2024.216951 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2024. Verfasst von Zheyi Wang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China; Institute o…. Hauptthemen laut MEDLINE: Neoadjuvant Therapy, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Immunotherapy. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 82 Literaturangaben. Gefördert von: Beijing Xisike Clinical Oncology Research Foundation, National Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neoadjuvant immunotherapy represents promising strategy in the treatment of esophageal squamous cell carcinoma (ESCC). However, the mechanisms underlying its impact on treatment sensitivity or resistance remain a subject of controversy. In this study, we conducted single-cell RNA and T/B cell receptor (scTCR/scBCR) sequencing of CD45+ immune cells on samples from 10 patients who received neoadjuvant immunotherapy and chemotherapy. We also validated our findings using multiplexed immunofluorescence and analyzed bulk RNA-seq from other cohorts in public database. By integrating analysis of 87357 CD45+ cells, we found GZMK + effector memory T cells (Tem) were relatively enriched and CXCL13+ exhausted T cells (Tex) and regulator T cells (Treg) decreased among responders, indicating a persistent anti-tumor memory process. Additionally, the enhanced presence of BCR expansion and somatic hypermutation process within TNFRSF13B + memory B cells (Bmem) suggested their roles in antigen presentation. This was further corroborated by the evidence of the T-B co-stimulation pattern and CXCL13-CXCR5 axis. The complexity of myeloid cell heterogeneity was also particularly pronounced. The elevated expression of S100A7 in ESCC, as detected by bulk RNA-seq, was associated with an exhausted and immunosuppressive tumor microenvironment. In summary, this study has unveiled a potential regulatory network among immune cells and the clonal dynamics of their functions, and the mechanisms of exhaustion and memory conversion between GZMK + Tem and TNFRSF13B + Bmem from antigen presentation and co-stimulation perspectives during neoadjuvant PD-1 blockade treatment in ESCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoadjuvant TherapyEsophageal Squamous Cell CarcinomaEsophageal NeoplasmsImmunotherapySingle-Cell AnalysisHumansFemaleMaleTumor MicroenvironmentAntineoplastic Combined Chemotherapy ProtocolsChemokine CXCL13Middle AgedAgedMemory T CellsLeukocyte Common AntigensT-Lymphocytes, RegulatoryReceptors, Antigen, B-CellReceptors, CXCR5

Substanzen

Chemokine CXCL13CXCL13 protein, humanLeukocyte Common AntigensReceptors, Antigen, B-CellReceptors, CXCR5

Autor:innen und Institutionen

  • Department of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China; Institute of Thoracic Oncology, Fudan University, Shanghai, China; Department of…
  • School of Life Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Hangzhou, China; State Key Laboratory of Cell Biology, Shanghai Institute of Biochem…
  • Department of Pathology, School of Basic Medical Sciences, Fudan University, Shanghai, China. Electronic address: li_fei@fudan.edu.cn.

Förderung

  • Beijing Xisike Clinical Oncology Research Foundation
  • National Natural Science Foundation of China
  • Science and Technology Commission of Shanghai Municipality

Zitieren

APA

Wang, Z., Zhao, Y., Wo, Y., Peng, Y., Hu, W., Wu, Z., Liu, P., Shang, Y., Liu, C., Chen, X., Huang, K., Chen, Y., Hong, H., Li, F., & Sun, Y. (2024). The single cell immunogenomic landscape after neoadjuvant immunotherapy combined chemotherapy in esophageal squamous cell carcinoma. Cancer Letters. https://doi.org/10.1016/j.canlet.2024.216951

Vancouver

Wang Z, Zhao Y, Wo Y, Peng Y, Hu W, Wu Z, et al. The single cell immunogenomic landscape after neoadjuvant immunotherapy combined chemotherapy in esophageal squamous cell carcinoma. Cancer Letters. 2024. doi:10.1016/j.canlet.2024.216951

BibTeX
@article{Wang2024,
  author = {Wang, Zheyi and Zhao, Yue and Wo, Yang and Peng, Yizhou and Hu, Weilei and Wu, Zhigang and Liu, Pengcheng and Shang, Yan and Liu, Chunnan and Chen, Xiao and Huang, Kan and Chen, Yuting and Hong, Hui and Li, Fei and Sun, Yihua},
  title = {The single cell immunogenomic landscape after neoadjuvant immunotherapy combined chemotherapy in esophageal squamous cell carcinoma},
  journal = {Cancer Letters},
  year = {2024},
  doi = {10.1016/j.canlet.2024.216951}
}
Kostenlos starten →